Company news

Nanexa AB news in 2026

Nanexa AB's news releases, calls and decks from 2026, newest first.

View company

Nanexa and Novo enter into EUR 1.165 billion global license and collaboration agreement for long-acting injectables

September 25, 2026

Nanexa publishes interim report for April - June 2026

August 27, 2026

Nanexa publishes interim report for January-March 2026

April 29, 2026

Nanexa resolves on set-off of outstanding loan

April 28, 2026

Nanexa announces exercise of warrants

April 2, 2026

Nanexa publishes annual report for 2025

March 26, 2026

Nanexa publishes year-end report and Q4 report 2025

February 19, 2026

Nanexa Announces Breakthrough Preclinical Data Demonstrating Exceptional Pharmacokinetic Profile for Monthly Semaglutide Formulation

January 27, 2026

Calls in 2026

Decks in 2026